These findings are quite similar to our results, suggesting that high expression of FoxP3 could activate immune-related pathways, recruit more Treg cells’ infiltration into the tumor microenvironment, and eventually promote immune evasion for cancer cells. The gene discussed is FOXP3; the disease is cancer.